InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Peripheral Vascular Chronic Total Occlusion Devices Market– (By Product (Crossing CTO devices, Extraluminal Devices, Balloon Catheters, Guidewires, Stents, Others), By End-Use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
According to the latest research by InsightAce Analytic, the Global Peripheral Vascular Chronic Total Occlusion Devices Market is expected to grow with a CAGR of 4.84% during a forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2732
Chronic Total Occlusion (CTO) devices are highly specialized medical tools designed for the treatment of fully obstructed arteries, particularly in cases where conventional interventions—such as bypass surgery or standard stent placement—are ineffective due to the complexity of the occlusion.
The global demand for CTO devices is on the rise, driven by an increasing incidence of vascular diseases associated with aging demographics, sedentary lifestyles, diabetes, and obesity. This heightened demand has intensified competition among industry players, fostering continuous innovation aimed at enhancing device efficacy and maintaining a strategic advantage in the marketplace.
Technological advancements in CTO device design and functionality have notably improved procedural success rates in the management of total arterial blockages. Furthermore, clinical techniques initially developed for the treatment of coronary artery disease are increasingly being adapted to address peripheral vascular conditions, thereby contributing to accelerated innovation and expanded application within the field.
List of Prominent Players in the Peripheral Vascular Chronic Total Occlusion Devices Market:
- Medtronic
- Boston Scientific Corporation
- Bard Peripheral Vascular, Inc.
- Terumo Medical Corporation
- Cordis
- Becton, Dickinson And Company
- Reflow Medical, Inc.
- Cook Medical
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics:
Drivers-
The sustained growth of the Chronic Total Occlusion (CTO) device market is driven by several critical factors, including the rising prevalence of cardiovascular conditions such as peripheral vascular disease and heart failure, as well as increased investments and funding directed toward the advancement of medical technologies. Notable innovations in the development of devices for treating peripheral vascular chronic total occlusions are further supporting market expansion.
In addition, the escalating global burden of diabetes and associated comorbidities is expected to significantly contribute to market growth over the forecast period. Data from the International Diabetes Federation (IDF) indicates that, as of December 2021, approximately 90 million individuals aged 20–79 in the South-East Asia (SEA) region were living with diabetes. This number is projected to rise to 113 million by 2030 and reach 152 million by 2045, underscoring a growing need for effective CTO treatment solutions.
Challenges:
The increasing reliance on anticoagulant therapies, particularly newer-generation agents such as Dabigatran, poses a challenge to the widespread adoption of peripheral vascular devices. These pharmacological treatments have emerged as frontline therapies for managing peripheral vascular disease (PVD), thereby reducing the need for surgical intervention.
Additionally, the growing effectiveness and use of medications such as statins for managing PVD further limit the demand for device-based treatments. Other non-invasive therapeutic alternatives—such as antiplatelet agents, vasodilators, cholesterol-lowering medications, and angiotensin-converting enzyme (ACE) inhibitors—are also increasingly prescribed for peripheral artery disease (PAD), thereby diminishing the necessity for invasive procedural approaches.
Regional Trends:
North America is expected to dominate the peripheral vascular Chronic Total Occlusion (CTO) device market in terms of revenue and is projected to witness the highest growth rate over the forecast period. This growth is primarily attributed to a rising geriatric population and a high prevalence of peripheral vascular disorders.
The presence of key industry players ensures broad access to advanced devices, while favorable reimbursement policies provided by Medicare and commercial insurance providers in the United States further support the market’s expansion. In the Asia-Pacific region, increasing demand for minimally invasive treatment options and the availability of peripheral vascular CTO devices tailored to such procedures are driving regional market growth.
Recent Developments:
- In Jan 2022, Becton, Dickinson and Company (BD) declared the introduction and 510(k) approval by the US FDA of the Crosser iQ chronic total occlusion (CTO) recanalisation system. This technology has been specifically developed to navigate peripheral artery CTOs intraluminally.
- In Oct 2020, Reflow Medical, Inc. announced that the Wingman CTO Catheter has been approved by the Pharmaceuticals & Medical Devices Agency (PMDA) of Japan. Reflow Medical has partnered with Century Medical, Inc. (CMI), a prominent distributor of medical devices headquartered in Tokyo, to introduce the Wingman CTO Catheter in Japan. Using an extendable bevelled point, the Wingman Catheter traverses peripheral CTOs.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2732
Segmentation of Peripheral Vascular Chronic Total Occlusion Devices Market-
By Application-
- Crossing CTO devices
- Extraluminal Devices
- Balloon Catheters
- Guidewires
- Stents
- Others
By End-User-
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
